Professional Documents
Culture Documents
Vitamin K Deficiency Bleeding (VKDB)
Vitamin K Deficiency Bleeding (VKDB)
Dr Rajesh Kumar MD (PGI), DM (Neonatology) PGI, Chandigarh, India Rani Children Hospital, Ranchi
3 months old child Fever 2 days, extreme irritability 1 day, bulging AF CT head done Prolonged PT and PTTK Corrected after Vit K and Plasma
07/03/07
07/03/07
07/03/07
07/03/07
11 months, 10.8 kg, OFC: 45.5 cm, sitting +, Stands with support
07/03/07
Early HDN
40 wks, term baby born NVD, had h/o seizure on phenobarbitone Baby had cephalhematoma, was hypotonic, Vit K was given USG head showed ICH Lab report :PT, PTTK increased
07/03/07
07/03/07
07/03/07
07/03/07
Vitamin K Deficiency
Incomplete carboxylation of coagulation proteins that do not form appropriate complexes with Ca&phospholip
BLEEDING
07/03/07 Dr Rajesh Kumar, MD (PGI, Chandigarh), DM (Neonatology, PGI, Chandigarh)
07/03/07
History
Haemorrhagic disease of newborn: Townsend 1894 Dam et al 1952: Parenteral vit K prevents Hgic disaese in newborn (n= 33,000) VKDB: Committee of the International Society on Thrombosis and Hemostasis in 1999 Method of prophylaxis: ?
07/03/07 Dr Rajesh Kumar, MD (PGI, Chandigarh), DM (Neonatology, PGI, Chandigarh)
07/03/07
Late VKDB
Incidence: 4.4 7.2 per lac With IM prophylaxis: 1.4 6.4 per lac
07/03/07
Limited placental transfer of Vit K; 30-60 % of adult value at birth Breast fed will have adult value by 6 weeks Formula fed has much higher value; 10 fold Lipid soluble Phytonadion (1 mg) injection at birth: Vit K level at 6 wks 1.5 times higher than breast fed babies
07/03/07 Dr Rajesh Kumar, MD (PGI, Chandigarh), DM (Neonatology, PGI, Chandigarh)
Pregnant mothers
Tablets of vit k 20mg/day in the last month of pregnancy--Improve blood levels of newborn Improve Vit K content of breast milk Esp. in mothers taking medications Must be given routinely
07/03/07
Refers to a group of 2-methyl-1,4naphthoquinone derivatives which can fulfill an essential co-factor function in humans in the biosynthesis of a number of calcium-binding proteins, some of which are essential for haemostasis. In nature,
vitamin K occurs as phylloquinone in plants menaquinones produced by bacteria.
07/03/07
Vitamin K1
Phylloquinone: found in dairy products, green vegetables, and vegetable oils, is an aqueous, colloidal solution of vitamin K1.
Phytomenadione Phytonadione Phytylmenadione 3-Phytylmenadione Phytylmenaquinone
07/03/07
Vitamine K2
Menaquinone, which is synthesized by gut flora.
Menatetrenone MK4 Vitamin K2(20) Vitamin MK4
07/03/07
Vitamine K 3
Menadione: It is a synthetic, water soluble form that is no longer used medically because of its ability to produce hemolytic anemia.
Menadione Menadione sodium bisulfite Menadiol Menadiol sodium phosphate Menadiol sodium phosphate hexahydrate
07/03/07
Vitamine K 4
Acetomenaphthone
07/03/07
Kaplin: Acetomenaphthone K-NAT: Vitamin K3, IM / IV (slow IV), Concerns about hemolytic anemia Kenadion: Vitamin K1, IM / IV (slow IV)
07/03/07
Vit K by IV route
07/03/07
Dose of Vit K1
07/03/07
Treatment of VKDB?
Vit K should be administered subcutaneously or intravenously but not intramuscularly to avoid hematoma formation at the site of injection Plasma should be administered to infants with serious bleeding manifestations.
07/03/07
Vit K prophylaxis
07/03/07
07/03/07
Vit K prophylaxis
07/03/07
Vit K prophylaxis
I.M. Vit K at birth Oral mixed miclellar Vit K (Konakion): 2 mg at birth, 7 days, 30 days ( many failures) Weekly oral Vit K (2 mg) for 3 months Oral 2 mg at birth, 25 mcg daily from 7 days to 3 months
07/03/07
07/03/07
Vitamin K1 should be given to all newborns as a single, intramuscular dose of 0.5 to 1 mg. Additional research should be conducted on the efficacy, safety, and bioavailability of oral formulations and optimal dosing regimens of vitamin K to prevent late VKDB. Health care professionals should promote awareness among families of the risks of late VKDB associated with inadequate vitamin K prophylaxis from current oral dosage regimens, particularly for newborns who are breastfed exclusively.
07/03/07
Oral Vit K1
Efficacy in oral administration is uncertain Oral administration contraindicated in
Premature, sick neonate, on antibiotic Cholestasis, diarrhea
07/03/07
1 ml TDS 1 -2 ml TDS
3 ml ABDEC
Vit A: Vit D:
15000 IU 1200 IU
3000 IU 1200 IU
3 ml VISYNERAL Z
Vit A: Vit D:
07/03/07
Evion drops: upto 10 ml per day UDCA (150 mg): 1 tab per day Syp Phenobarb: 6 ml per day Vit D: 5000- 8000 IU per day Vit A: 10,000 15000 per day
07/03/07